-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/improved-cancer-outcomes-protocol_0.pdf
December 01, 2021 - characteristics, including age at diagnosis, tumor type, stage of disease, type of
cancer treatment … (such as Head and Neck, Breast, Multiple Cancers, etc.) and
report the intervention comparisons and … Walsh D, Szafranski M, Aktas A, Kadakia KC. … emia* or melanoma* or myeloma* or neoplasm* or radiotherap* or radiation therap*).ti,ab. … or exp Neoplasms/ or chemoprevention/ or chemoradiotherapy/ or chemoradiotherapy, adjuvant/
or chemotherapy
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-radiation_technical-brief.pdf
November 01, 2009 - (e.g., lung, prostate, breast) and uncommon cancers (e.g., skull base
tumors, uveal melanomas). … cancer)
• Head and neck cancers, including malignancies of the brain (e.g., glioblastoma); of
the … the sclera for some ocular
cancers or in the uterus for some gynecologic malignancies), or may be directly … ), and cancers of the head and neck (brain tumors, and tumors arising from skull base,
cervical spine … Treated cancers included malignant tumors in the head, neck and spine, non-
small cell lung cancer, prostate
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/vaccine-safety_research-protocol.pdf
September 18, 2012 - d. What AEs are associated with these vaccines in the fetus/infant?
1. … D. … United States Cancer Statistics: 1999–2008
Incidence and Mortality Data. … Ball R, Horne D, Izurieta H,et al. … Owens DK, Lohr KN, Atkins D, et al.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/undescended-testicle_research-protocol.pdf
September 02, 2011 - An estimated 10 percent of all testicular tumors develop from an undescended testis,
9
and
the relative … risk of incidence of a testicular tumor is about 40 times greater in men with
cryptorchidism when … Testicular malignancy and cancer
9. Hernia
10. … D. … Wells G, Shea B, O’Connell D, et al.
-
effectivehealthcare.ahrq.gov/products/undescended-testicle/research-protocol
September 02, 2011 - An estimated 10 percent of all testicular tumors develop from an undescended testis, 9 and the relative … risk of incidence of a testicular tumor is about 40 times greater in men with cryptorchidism when compared … D. … Each key outcome on each comparison of interest will be given an overall evidence grade based on the … Wells G, Shea B, O’Connell D, et al.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-decision-support-tools_research-protocol.pdf
November 12, 2013 - For
example, choosing to remove or destroy a low-grade prostatic malignancy can lead to
complications … D. … Saslow D, Solomon D, Lawson HW, et al. … "[Mesh] OR cancer OR cancers OR neoplasm* OR malignan* OR premalignan* OR
precancerous OR hypertrophy … "[Mesh] OR cancer OR cancers OR
neoplasm* OR malignan* OR premalignan* OR precancerous))
Filters:Publication
-
effectivehealthcare.ahrq.gov/sites/default/files/s123.pdf
October 01, 2007 - stage, grade and tumor location, age,
payer, comorbidities, patients distance to nearest hospital,
and … Differences re-
mained in the distributions of age and tumor grade across
patients grouped by the instruments … Iowa Cancer Registry
officials suggested that grade distribution differences re-
flected different reporting … sizes (�2,
2–5, and 5� cm), positive lymph node involvement, tumor grade groups (1, 2, 3, 4, 9-unknown … sizes (�2, 2–5, and 5� cm), positive lymph node involvement,
tumor grade groups (1, 2, 3, 4, 9-unknown
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/improving-utility-evidence-synthesis-white-paper.pdf
April 01, 2021 - GRADE Working Group. 2013.
3. … Snyder D, Sullivan N, Margolis D, et al. Skin
substitutes for treating chronic wounds. … Writing Committee of the Breast Cancer
Working Group, Cancer Intervention and
Surveillance Modeling … sensitivity, specificity,
positive and negative
predictive values) in
screening for
gynecological cancers … D-1
Appendix D. Review of Technical Briefs
Table D-1.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/breast-abnormalities-tests-update_executive.pdf
February 01, 2012 - is one of the most
common malignancies of women, with
approximately 200,000 new cases
diagnosed … The grade was developed by considering four important
domains: the risk of bias in the evidence base … Breast Cancer. 2001;8(2):116-24.
PMID: 11342984
47. Torheim G, Godtliebsen F, Axelson D, et al. … Fluorine-18
2-deoxy-2-fluoro-D-glucose PET in the preoperative staging of
breast cancer: comparison … D galactose-based
signal-enhanced color Doppler sonography of breast tumors and
tumorlike lesions.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/crohns-disease_executive.pdf
February 01, 2014 - Cervical cancer (insufficient
data to estimate incidence)
Low The risk of cervical cancer did not differ … reported on cervical cancer. … All cancers (insufficient data
to estimate incidence)
Low The risk of nonmelanoma skin cancer was higher … All cancers (insufficient data
to estimate incidence)
Low The risk of nonmelanoma skin cancer was higher … All cancers (insufficient data
to estimate incidence)
Low The risk of other cancers did not differ
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/observational-studies_white-paper.pdf
December 01, 2013 - Norris S, Atkins D. … Chou R, Aronson N, Atkins D, et al. … The GRADE Working Group. GRADE
guidelines: 9. Rating up the quality of
evidence. … Norris S, Atkins D, Bruening W, et al. … Chou R, Hartung D, Rahman B, Wasson N, Cottrell E, Fu R.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/vaccines-safety-protocol-130325.pdf
September 18, 2012 - d. What AEs are associated with these vaccines in the fetus/infant?
1. … D. … United States Cancer Statistics: 1999–2008
Incidence and Mortality Data. … Ball R, Horne D, Izurieta H,et al. … Owens DK, Lohr KN, Atkins D, et al.
-
effectivehealthcare.ahrq.gov/products/cancer-pancreas/research-protocol
August 09, 2013 - Diagnostic management of pancreatic cancer. Cancers. 2011 Mar;3(1):494-509. … Moher D, Pham B, Klassen TP, et al. … / or exp pancreas, exocrine/) and (neoplasm/ or adenocarcinoma/ or
neoplasms/)) or pancreas tumor … r$ or sarcoma$ or neoplasm$ or
carcinoma$ or adenocarcinoma$)).mp.
4
neuroendocrine tumors … and imaging and diagnosis
17 and 23
25
Staging
Cancer staging/ or Neoplasm staging/
26
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/colorectal-cancer-liver-metastases-therapies_disposition-comments.pdf
December 11, 2012 - PFS where presented is in the appendix D. … This will not impact the
overall GRADE conclusions. … Size and number of
tumors is not relevant for stratifying embolotherapy patients; instead, %
tumor … We have added these to appendix D. … In contrast, image-guided therapies treat tumors
piecemeal.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/people-with-disabilities-protocol.pdf
January 16, 2024 - A and Grade B recommendations:
- Screening (anxiety disorders, breast cancer, cervical cancer,
colorectal … Each included preventive service
has a Grade A or Grade B recommendation from the United States Preventive … Wells M, Turner S, Martin D, et al. … Atkins D, Chang SM, Gartlehner G, et al. … Because having a
USPSTF Grade A or Grade B
recommendation is an inclusion
criterion for the systematic
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/grades-predictive-values_white-paper.pdf
September 01, 2015 - Atkins D, Siegel J, Slutsky J. Making policy
when the evidence is in dispute. … Owens DK, Lohr KN, Atkins D, et al. … Lemiengre MB, van Driel ML, Merenstein
D, et al. … Trastuzumab containing regimens for early
breast cancer. … Schunemann HJ, Best D, Vist G, et al.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/dyspnea-protocol-amended.pdf
May 19, 2020 - Supplemental oxygen therapy (for hypoxemic and non-hypoxemic patients)
d. … Respiratory training
d. Pulmonary rehabilitation
e. Chest wall vibration
f. … Reiki
d. Mindfulness
e. Yoga
f. Meditation
g. … Strength of Evidence (SOE) for Major Comparisons and
Outcomes: At the completion of our review, we will grade … a key outcome includes both RCTs and other
intervention studies with a comparison group, we will grade
-
effectivehealthcare.ahrq.gov/sites/default/files/prostate-cancer-therapies-summary.pdf
September 01, 2020 - Effects may not vary by patient or tumor factors. … one of the most
frequently diagnosed cancers among U.S. men (191,930 new cases) and the second leading … cause
of cancer death (33,330).1 In 90 percent of newly diagnosed cancers, the disease is confined … We modified AHRQ
methods for this review by using GRADE and EPC tools for risk of bias and certainty … Higgins JPT, Altman D, Sterne J. Chapter 8:
Assessing risk of bias in included studies.
-
effectivehealthcare.ahrq.gov/products/uterine-fibroids/research-protocol
February 29, 2016 - background
Most women will develop one or more uterine fibroids (i.e., leiomyomata), benign smooth muscle tumors … among those with symptoms in part due to earlier age at onset of fibroids with larger and more numerous tumors … address the potential harms associated with morcellation, as well as an exploration of patient and tumor … Zimmermann A, Bernuit D, Gerlinger C, et al. … Shamseer L, Moher D, Clarke M, et al.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-antigen-3-gene_research.pdf
April 01, 2013 - The prostate cancer
antigen-3 gene (PCA3) has recently been found to be overexpressed in prostate cancers … : 3 2012 ASCO Conference Abstracts
D-1
Appendix D. … Table D.1. … Table D.2. … D-3
25. Schilling D, Hennenlotter J, Munz M, et al.